A GRACE study analysis reveals that, among treatment-experienced patients, African-American women are significantly less likely than their white counterparts to achieve an undetectable viral load on HIV treatment. Lead author Kimberly Smith, M.D., M.P.H., points to two possible explanations: Black women were more likely to drop out of the study entirely, and those who remained were less likely to adhere to their therapy.